LEAFBIO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Nov 2022)
What this means for you
Registered since 31 May 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85710504
- Registration number
- 4969019
- Mark type
- Stylized text
- Filed
- 22 Aug 2012
- Published for opposition
- 29 Jan 2013
- Registered
- 31 May 2016
- Attorney of record
- Paul Nardulli
Goods and services
- Class 001 — Chemicals: Diagnostic reagents for scientific or research use; [ Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; ] Diagnostic reagents for clinical or medical laboratory use; [ Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; ] Diagnostic reagents for scientific or research use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; [ Reagent for chemical analysis; ] Reagents for research purposes; Reagents for scientific or medical research use; [ Reagents for testing the sterility of pharmaceuticals and injectable solutions; ] Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for use in biodefense
- Class 005 — Pharmaceuticals: Pharmaceutical products for use in the treatment and prevention of [ cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, ] viral and infectious diseases, [ cancer, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, ] inflammation and inflammatory diseases and disorders, [ metabolic diseases and disorders, ] respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, [ psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, ] sexually transmitted infections including, but not limited to, HIV, HPV, and herpes [, and hemolytic diseases and disorders; Pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, urological preparations, ophthalmologic preparations, tissue and skin repair preparations and gynecological preparations ] ; Pharmaceuticals, namely, anti-infectives; [ Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids, including for microorganisms; Drug delivery agents consisting of compounds that facility delivery of a wide range of pharmaceuticals; ] Antibacterial pharmaceuticals; [ Cardiovascular pharmaceuticals; ] Contraceptive foams, sponges, preparations; [ Oral contraceptives; ] Pharmaceutical products for use in biodefense
- Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment and prevention of [ cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, ] viral and infectious diseases, [ cancer, urological diseases and disorders, ] gastrointestinal diseases and disorders, [ musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, ] inflammation and inflammatory diseases and disorders, [ metabolic diseases and disorders, ] respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, [ psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, ] sexually transmitted infections including, but not limited to, HIV, HPV, and herpes [ and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, urological preparations, ophthalmologic preparations, tissue and skin repair preparations and gynecological preparations ] ; research and development of drug delivery devices; medical and scientific research, namely, conducting clinical trials; Consulting services in the fields of biotechnology, pharmaceutical research and development, [ laboratory testing, diagnostics, ] and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development; Pharmaceutical research and development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; [ Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; ] Pharmaceutical research and development in relation to biodefense
Owner
- LeafBio, Inc., San Diego, CA, US
- LeafBio, Inc., San Diego, CA, US
- LeafBio, Inc., San Diego, CA, US
Prosecution history
- 01 Jun 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Nov 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Nov 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Nov 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 May 2022 — TEAS SECTION 8 & 15 RECEIVED
- 31 May 2016 — REGISTERED-PRINCIPAL REGISTER
- 26 Apr 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
- 23 Apr 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Apr 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Mar 2016 — USE AMENDMENT FILED
- 17 Mar 2016 — TEAS STATEMENT OF USE RECEIVED
- 29 Sept 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
- 27 Sept 2015 — SOU EXTENSION 5 GRANTED
- 09 Sept 2015 — SOU EXTENSION 5 FILED
- 09 Sept 2015 — SOU TEAS EXTENSION RECEIVED